Read + Share
Amedeo Smart
Independent Medical Education
Mahaffey KW, Tuttle KR, Arici M, Baeres FMM, et al. Cardiovascular outcomes with semaglutide by severity of chronic kidney disease in type 2 diabetes: the FLOW trial. Eur Heart J 2024 Aug 30:ehae613. doi: 10.1093.PMID: 39211948
Email
LinkedIn
Privacy Policy